Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX

There are several reports on the correlation between early tumor shrinkage (ETS) or depth of response (DpR) and survival in chemotherapies for colorectal cancer; however, few studies have investigated it in pancreatic cancer. We therefore investigated whether the ETS will predict outcomes in 59 pati...

Full description

Saved in:

Bibliographic Details
Published in:	Oncotarget Vol. 7; no. 41; pp. 67314 - 67320
Main Authors:	Kaga, Yasuhiro, Sunakawa, Yu, Kubota, Yutaro, Tagawa, Teppei, Yamamoto, Taikan, Ikusue, Toshikazu, Uto, Yu, Miyashita, Kouichirou, Toshima, Hirokazu, Kobayashi, Kouji, Hisamatsu, Atsushi, Ichikawa, Wataru, Sekikawa, Takashi, Shimada, Ken, Sasaki, Yasutsuna
Format:	Journal Article
Language:	English
Published:	United States 11.10.2016
Subjects:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Disease-Free Survival Female Humans Kaplan-Meier Estimate Male Middle Aged Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - mortality Pancreatic Neoplasms - pathology Prognosis Treatment Outcome FOLFIRINOX pancreatic cancer early tumor shrinkage
ISSN:	1949-2553
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!